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The purpose of this study was to examine the test-retest reliability for peak torque 
(PT), rates of torque development (RTD), and electromechanical delay (EMD) calculated 
during voluntary and evoked muscle actions in men ages 65 and older. Fifteen older men 
(mean ± standard deviation (SD) age = 72.3 ± 7.3 years) completed 3 evoked and 3 
voluntary isometric muscle actions of the leg extensors during two visits separated by 48 
to 72 h. PT and EMD were calculated during voluntary and evoked muscle actions. RTD 
was quantified as the peak RTD, overall RTD, RTD in time intervals of 0-30 (RTD30), 0-
50 (RTD50), 0-100 (RTD100), and 0-200 ms (RTD200) from the onset of torque, and 
RTD in 10 ms epochs during the first 250 ms after the onset of torque or to peak torque 
for voluntary and evoked muscle actions. Intraclass correlation coefficients (ICCs), 
standard errors of measurement (SEMs), and coefficients of variation (CV) were used to 
quantify the test-retest reliability. Voluntary and evoked PT demonstrated good 
reliability, whereas EMD can be considered unreliable. The ICCs for voluntary PRTD, 
RTD30, RTD50, RTD100, RTD200, and overall RTD ranged from 0.598-0.799, while for 
evoked PRTD, RTD30, RTD50, RTD100, and overall RTD, ICCs ranged from 0.943-
0.984. Voluntary RTDs in 10 ms epochs had ICCs ranging from 0.179-0.939, while 
evoked RTD in 10 ms epochs demonstrated ICCs ranging from 0.693-0.975. Except for 
PRTD and RTD in 10 ms epochs after 50 ms, CVs were higher for voluntary (11-41%) 
than evoked (7-24%) measures. Systematic decreases occurred from trial one to trial two 
for several voluntary measures of RTD, while there was only one for the evoked 
measures of RTD. CONCLUSIONS: There is dissociation in the reliability of voluntary 
and evoked PT, and RTD, such that the evoked measurements display greater reliability 
in older men.  Voluntary RTDs were most suspect, consistently demonstrating lower 
ICCs and greater SEMs than evoked RTD. However, if choosing to measure voluntary 
RTD in older men, the most reliable measurements may be RTD in the first 10 ms, 80-
110 ms, or overall RTD. Finally, EMD may be unreliable in older men.  
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CHAPTER I 
INTRODUCTION  
 Sarcopenia is defined as the age-related loss of skeletal muscle mass (7) and 
function (39) and is associated with physical disability and functional impairment (34). 
Estimates on the prevalence of sarcopenia report rates ranging from 5-13% in adults ages 
60-70 years old and from 11-50% in adults 80 years and older (20,60). Using 
conservative estimates, sarcopenia currently affects 50 million people and will affect 200 
million within the next 40 years (18). Clinically, sarcopenia is defined as a combination 
of low grip strength or gait speed and relative skeletal muscle mass ≥ 2 standard 
deviations below a reference sample (20). When comparing genders, sarcopenia develops 
at a faster rate in men than in women across the age span (21,24,33); therefore, men and 
women are often studied separately regarding sarcopenic muscle function. Moreover, 
there is a dissociation between the loss of skeletal muscle mass and the loss of muscle 
strength with sarcopenia (60). Metter et al. (45) reported age-related decreases in strength 
independent of changes in muscle mass for adults from 18 years to 93 years of age and 
suggested that “muscle quality” be used as a relative index (strength ÷ muscle mass) by 
which to monitor changes with aging and sarcopenia. Identifying reliable measures of 
skeletal muscle mass, strength, function, and muscle quality will be important to 
understand the complex physiological changes that occur in skeletal muscle with age.  
 Consistent with sarcopenia is the elevated risk of falls in the elderly. Falls occur 
in 30% of adults aged 65 years and older (26) and in 50% of adults aged 80 years and 
older every year (58). Falling-related injuries are the sixth leading cause of death among 
the elderly (57). In fact, 50% of elderly adults who are hospitalized due to a fall will have 
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a one-year survival rate (49). Therefore, exploring reliable measurements of muscle 
function that not only characterize sarcopenia, but also provide insight regarding the 
ability to avoid falls is of paramount importance. The recovery of balance following a 
destabilizing perturbation requires a rapid and forceful response (63). Andersen and 
Aagaard (4) previously defined the rate of torque development (RTD) as the “ability to 
rapidly develop muscle force” (pg. 47). Thus, RTD may be an important variable to 
monitor for reducing the risk of falls in the elderly (10,32,48,56). The electromechanical 
delay (EMD) is the time lag between the onset of electrical activity in a muscle and the 
onset of a measureable torque response (18,61,67) that is influenced by the series elastic 
component (SEC; 18). The SEC may change with age (36). Consequently, the EMD may 
be sensitive to age-related changes in muscle quality or stiffness that effect reaction time 
and RTD. However, RTD (2,10,37,48,56) and EMD (65) have only recently been studied 
in the elderly. Therefore, measuring these variables reliably, in addition to skeletal 
muscle mass and strength, may help to clarify the age-related changes in muscle function 
to better explain sarcopenia.  
 Christ et al. (19) stated that “…fear of injury may serve as an inhibitory 
mechanism in older, sedentary adults” (pg 503). This statement implied that central 
nervous system inhibition may influence measures of muscle function during voluntary 
muscle actions in the elderly. Variables such as muscle force production, RTD, and EMD 
can be measured during evoked muscle actions by stimulating the peripheral motor nerve 
that innervates the muscle or muscle group being studied. In theory, evoked muscle 
actions would not be influenced by motivation or central inhibition. Ishida et al. (31) 
suggested that the central component of muscle activation could be removed when using 
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evoked muscle actions. Therefore, a direct comparison of the reliability of evoked versus 
voluntary muscle actions may be helpful to examine the efficacy of these measures of 
muscle function in the elderly.  
 Given the recent focus of exercise- and nutrition-based interventions to reduce the 
negative impacts of sarcopenia (16,30,47), it is important to understand the reliability of 
variables used to quantify muscle function in the elderly. For example, Baier et al. (6) 
examined the effects of once-daily supplementation with either hydroxy-β-
methylbutyrate, L-arginine, and L-lysine over a one-year period on protein turnover, 
body composition, isokinetic leg extensor and flexor strength, hand-grip strength, and 
functionality in elderly men and women. This study indicated that this blend of amino 
acids increased whole body protein turnover and lean body mass in the elderly, however, 
it did not result in increased strength or functional performance. Reliability of voluntary 
peak torque (PT) and evoked twitch properties has been examined in the dorsi- and 
plantar-flexors of elderly men and women (64) and in the leg extensors of elderly women 
(17). Buckthorpe et al. (14) recently reported reliability for evoked and voluntary RTD 
and PT in young, healthy adults. However, to our knowledge, no previous studies have 
established test-retest reliability of PT, RTD, or the EMD in the leg extensors of elderly 
men. Therefore, the purpose of this study will be to examine test-retest reliability for PT, 
RTD, and EMD calculated during voluntary and evoked muscle actions in elderly men.  
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CHAPTER II 
REVIEW OF LITERATURE 
2.1 Historical Perspective of Evoked and Voluntary Contractions 
2.1.1. Asmussen and Heeboll-Nielsen (5) 
 The purpose of this investigation was to determine the changes in muscular 
strength that occur during aging using voluntary isometric contractions. Isometric muscle 
strength was measured in 25 muscle groups in 360 men and 250 women, ages 15 to 60. 
Maximal isometric force was measured via strain gauge dynamometers. The measured 
values were then grouped and averaged according to the age of the subjects. The over-all 
change in isometric strength was determined by expressing the measured values as a 
percentage of strength in the same muscle group of 20 to 22 year old men 
(i.e.   !"#$%&"!  !"  !!!!"  !"  !"#  !"#$!"#$%&"!  !"  !"!!!  !"  !"#  !"#$ ∗ 100). The results showed that isometric strength 
increases in men until the age of 30 and then begins to decline. By age 60, isometric 
strength is 90% that of 20-22 year olds. In women, isometric strength fails to increase 
appreciably after the age of 20 and is about 65% of aged matched men. After age 40, 
women’s strength decreases more rapidly than men’s, such that by age 55, women’s 
strength is only 54% that of aged matched men. There is also a difference in the rate of 
decline in strength of the upper and lower limbs. Maximum lower limb strength is 
reached later in life than upper limb strength, but declines more rapidly than in the upper 
limbs.  
2.1.2. Merton (44) 
 The purpose of this study was to compare voluntary tension with the tension 
elicited from electrically elicited motor volleys to determine the ability of a maximal 
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tetanic stimulus to maximally activate the contractile mechanism, voluntary activation, 
and the contribution of the central nervous system to fatigue during a sustained 
contraction. 
 Maximal stimuli were applied to the ulnar nerve at the wrist in order to cause 
contraction of the adductor pollicis, which is the only ulnar-nerve supplied muscle acting 
on the thumb. Therefore, the force produced by the electrical stimuli and by the voluntary 
adduction could be compared. A special splinting device was used to stabilize the hand at 
the wrist joint. The amplified action potentials from surface-electromyography and the 
mechanical force were recorded and then photographed on cathode-ray tubes.   
The results of the first experiment in this study indicated that a 50 Hz tetanic 
stimulus was capable of maximally activating the contractile mechanism. The second 
experiment demonstrated that during a maximal voluntary effort, maximal activation of 
the adductor pollicis occurred. The third experiment showed that, during fatiguing 
contractions, the superimposed stimuli did not result in an increase in force, which 
demonstrates that the fatigue was largely, if not completely, due to peripheral factors. The 
authors speculated that failure of the contractile processes may be due to ischemia. In 
addition to the above results, this article demonstrates how electrical stimuli can be used 
to study neuromuscular function.  
2.1.3. Bigland-Ritchie, Jones, Hosking, and Edwards (12) 
 The purpose of this study was to determine the cause of fatigue during a 
sustained, 60-second maximal voluntary contraction of the quadriceps femoris muscle in 
nine healthy adults (ages 25-50 years). Force and EMG were recorded from the subjects 
while they were seated on an adjustable chair fitted with a strain gauge. Electrical stimuli 
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were delivered to the vastus lateralis (VL) transcutaneously via the femoral nerve or 
percutaneously on the muscle belly with surface pad electrodes. Subjects then performed 
sustained, 60-second maximal voluntary contractions (MVC), during which the force fell 
by an average of 30%. The central and peripheral contributions to fatigue were tested in 
one subject by stimulating the femoral nerve throughout the sustained MVC. If central 
fatigue were present, the MVC force would theoretically decline more rapidly than would 
the tetanic force produced by the electrical stimuli. During the first 30s, the voluntary and 
stimulated contractions declined equally. However, after 45s, the voluntary force was less 
than the force produced by the electrical tetani. This demonstrated that during the first 30 
s, fatigue was due to failure at or distal to the myoneural junction but after 45 s central 
drive contributed to fatigue. The same protocol was then repeated in the remaining 
subjects using percutaneous stimulation of the muscle belly. In five of these subjects, 
central fatigue accounted for 10 to 30% of the force loss after 60 s. In the other four, there 
was little evidence of central fatigue. This study demonstrated the simultaneous use of 
evoked and voluntary muscle actions in order to determine the mechanisms of fatigue.  
2.2 Common Measures of Neuromuscular Function 
2.2.1 Zhou, Lawson, Morrison, and Fairweather (67) 
The purpose of this study was to investigate the differences in EMD of the leg 
extensor muscles during isometric contractions evoked by reflex, voluntary, and electrical 
stimulation. Twenty-one healthy young women (n=5) and men (n=16) (mean±SD age = 
22.7±6.5 years, height = 175.9±7.3 cm, and weight = 68.7±10.6 kg) volunteered for this 
study. Electromechanical delay was measured in the vastus lateralis (VL) and rectus 
femoris (RF) while subjects were seated in a chair with a knee joint angle of 90° and a 
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hip joint angle of 120°. Isometric force was measured via a load cell that was fixed to the 
subject’s leg just above the ankle. The EMD was calculated as the difference between the 
point in time at which EMG activity began and the onset of torque development. EMD 
was calculated at 30%, 60%, and 90% of maximal voluntary contraction (MVC); tendon 
reflex at 60°, 75°, and 90° angles, as well as electrically evoked muscle actions at 
intensities of 150 V, 120 V, and 90 V. Total reaction time, peak contraction force, peak 
rate of force development (RFD), the time to peak force, and muscle fiber conduction 
velocity were also assessed.  
The results of this study demonstrated that EMD was longest (p<0.05) at 30%. 
MVC. Further, EMD was significantly longer (p<0.05) during the voluntary conditions 
compared to the reflex or electrically evoked conditions. EMD was significantly shorter 
(p<0.05) during 150V electrically evoked muscle actions than in all other conditions. 
Peak forces of the electrically evoked muscle actions were 5.8%, 10.1%, and 14.6% of 
MVC at 90 V, 120 V, and 150 V, respectively. Peak rate of force development was 
significantly higher (p<0.05) in the voluntary condition than in TR or ES. The time to 
peak force was significantly longer (p<0.05) in the voluntary condition than in TR or ES. 
Furthermore, the time to peak force in ES was significantly lower (p<0.05) than the other 
conditions. The EMD was significantly correlated (p<0.05) to the peak force of the 
voluntary, ES, and TR contractions and to the peak RFD of MVC. The authors speculated 
that the relationship between evoked peak force and EMD may be related to the 
contractile properties of the muscle. 
2.2.2. Bilodeau, Houck, Cuddeford, Sharma, and Riley (13) 
	   	  
	  
8	  
 The purpose of this study was to determine if a greater association between the 
frequency content of EMG and rate of torque development (RTD) existed during either 
voluntary or evoked contractions of the forearm flexors. The author’s hypothesized that a 
stronger association between the frequency content of EMG and the RTD would be found 
in evoked muscle actions, due to the elimination of confounding factors during voluntary 
conditions. Twenty-three healthy adults (mean ± SD age = 28.4 ± 5.5, height = 1.70 m ± 
0.10, weight = 65.5 ± 12.8) volunteered to participate in this study. Condition 1 consisted 
of ballistic muscle actions at four randomly assigned target torques at 20, 40, 60, and 
100% of maximal voluntary contraction (MVC). During condition 2, m-waves and twitch 
torques were evoked from the biceps brachii and brachioradialis while at rest as well as 
during an isometric contraction at 15% MVC. The mean power frequency (MPF), median 
frequency (MF), and rate of torque development (RTD) were then calculated for both 
voluntary and evoked conditions. The RTD was calculated from three different torque 
sectors: 10-40%, 40-70%, and 10-70% MVC.  
 The results of condition 1 indicated that RTD increased progressively as the target 
torque level increased. The MPF and MF of the brachioradialis and the MPF of the biceps 
brachii also increased as target torque level increased. There were significant correlations 
(p<0.05) between MPF, MF, and RTD at target torques of 20% and 40% MVC in the 
biceps brachii. In the brachioradialis, significant correlations (p<0.05) were observed at 
40% and 60% of MVC. The results of condition 2 revealed significant (p<0.05) negative 
correlations between RTD and m-wave MPF (r=-0.64), with RTD calculated at 40-70% 
MVC for the biceps brachii short head while subjects contracted at 15% MVC. There 
were also significant negative correlations for the brachioradialis both at rest (r=-0.49 to -
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0.57) and while subjects contracted at 15% MVC  (r= -0.55 to -0.58) for all three 
calculations of RTD (10-40%, 40-70%, and 10-70% MVC).  
 These results suggest that factors other than muscle fiber composition influence 
the MPF and the RTD. The author’s hypothesized that the relative contribution of these 
factors varies between conditions. The results of this study suggest that the factors that 
influence RTD and the frequency content of EMG vary dependent upon the contraction 
type. 
2.3 Previous Reliability Studies 
2.3.1. Winegard, Hicks, and Vandervoort (64) 
 The purpose of this study was to examine the reproducibility of isometric twitch 
properties and voluntary strength in elderly subjects. Ten subjects (five male and five 
female) ages 73 to 97 years were tested on two days separated by one week. All of the 
subjects were able to walk independently and were also involved in light physical 
activities. Measurements were recorded while the subjects sat in an upright chair with 
their leg flexed at 90°. A footplate apparatus was used to record isometric twitch 
properties and voluntary strength of the dorsiflexor and plantar flexor muscles. All 
measurements of the plantar flexors and dorsiflexors were performed with the ankle at 
30° and 10° of flexion, respectively. Electrical stimuli were delivered to the common 
peroneal nerve in order to elicit twitches in the dorsiflexors and to the tibial nerve to elicit 
contractions in the plantarflexors. The stimuli were delivered via a constant current 
stimulator in single 50µs pulses. The stimulation voltage was progressively increased 
until a plateau in twitch torque was seen. This voltage was then used to elicit maximal 
twitches. Compound muscle action potentials (M-waves) were recorded via EMG 
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electrodes placed on the tibialis anterior and the gastrocnemius. The subjects performed 
maximal voluntary contractions (MVC) during both plantar- and dorsiflexion while a 
stimulus was applied in order to determine the level of voluntary activation. The MVC 
attempts were performed until either an interpolated twitch was no longer present or the 
torque output reached a plateau.  Following this, the subjects performed a 5 second MVC 
followed 3 seconds later by an evoked twitch in order to determine postactivation 
potentiation.  
The ICCs of the resting evoked plantar- and dorsiflexor measurements ranged 
from 0.80 to 0.97. The method errors ((√MS error/mean score) x 100%) ranged from 5.17 
to 12.30%. The ICCs and method errors for voluntary peak torque of the plantar- and 
dorsiflexors were .97 and .98 and -8.95 and 5.96%. This study showed that isometric 
twitch properties and voluntary peak torque measurements in the elderly demonstrate 
acceptable reliability.  
2.3.2. Cannon, Kay, Tarpenning, and Marino (17) 
 The purpose of this study was to determine the effect of resistance training on 
evoked twitch properties in young and old women and to evaluate the reproducibility of 
evoked twitch measurements.  
 Nine young (mean ± SD; age 25.0 ± 4.0 yrs, height 167.7 ± 7.6 cm, mass 71.4 ± 
10.1 kg, and BMI 25.9 ± 4.5 kg/m2) and ten elderly (67.1 ± 6.6 yrs, 166.0 ± 6.0 cm, 69.5 
± 12.7 kg, and BMI 27.1 ± 4.2 kg/m2), moderately active women volunteered to 
participate in this study. The data obtained from the first and third weeks of testing were 
used to determine the reproducibility of the measurements. Data from the third week was 
used to examine age-related differences. Finally, a 10-week resistance-training program 
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was performed from week three to week thirteen. Data were obtained during the 
resistance training program at weeks 0, 3, 6, and 10.  
 Evoked twitch properties and MVC of the right leg extensors were assessed on a 
Kin-Com isokinetic dynamometer with subjects seated upright with the hip flexed at 75° 
and the knee flexed at 60°. The variables measured from the evoked muscle actions 
included: peak twitch torque, time to peak torque, half-relaxation time, contraction 
duration, rate of torque development, and rate of relaxation. This study also determined 
the reproducibility of evoked twitch properties by using the Pearson’s r, intraclass 
correlation coefficient (ICC), and the technical error of the measurement (TEM). 
 The results of this study demonstrated significant differences (p<0.05) between 
young and old women concerning peak torque, rate of torque development, and rate of 
relaxation and that the variables measured in this study could be repeated.  
2.3.3. Buckthorpe, Hannah, Pain, Folland (14) 
 The purpose of this study was to determine the between-session reliability of 
voluntary and involuntary leg extensor measurements of explosive force production and 
agonist EMG during the initial phases of explosive contractions and at maximal force.  
Thirteen physically active, healthy men (mean age ± SD = 22 ± 3 yrs; height = 178 ± 4.0 
cm; body mass = 70.6 ± 9.2 kg) visited the laboratory on four separate occasions. The 
subjects were seated with the hip and knee joint angles set at 100° and 85°, respectively. 
Surface EMG was recorded from the rectus femoris, vastus lateralis, and vastus medialis. 
Subjects completed four, three-second isometric maximal voluntary contractions (MVC) 
and 10 explosive voluntary contractions. From the explosive contractions, force was 
measured at 50, 100, and 150 ms from the onset of contraction; impulse and rate of force 
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development (RFD) was measured as peak slope (pRFD) and in windows of 0-50, 50-
100, and 100-150 ms after the onset of contraction. RMS EMG was measured from 0-50, 
50-100, and 100-150 ms after the initiation of EMG activity.  
Involuntary contractions were produced with supra-maximal twitches and with 
supra-maximal octets. The Mmax P-P and total Mmax area obtained for each muscle 
during these twitches was used for normalization of the voluntary EMG. The twitch 
force-time curve was also analyzed for peak force (TPF), force at 50 ms (TF50), pRFD in 
a 2ms time window (pRFD), impulse from 0-50 ms (TI50), time to peak force (TPF), and 
half relaxation time (HRT) for both single twitch and octect muscle actions. Inter-class 
correlation coefficients (ICC) and coefficient of variations (CV) were calculated for each 
variable. 
The maximal voluntary force showed excellent reliability across sessions 
(ICC=0.95). Absolute EMG amplitudes during maximal and submaximal contractions 
were consistent (ICC=0.89-0.91). The ICCs for the force, RFD, and impulse at each of 
time windows (i.e. 0-50, 50-100, and 100-150ms) during voluntary explosive 
contractions ranged from 0.62 to 0.91. The CVs for these four variables during the 50-
100 and 100-150ms windows ranged from 5.1-10.5%. The force responses to the octet 
stimulations had ICC values ranging from 0.71-0.82 and CV values ranging from 5.4-
7.3%. The CV values for force, force at 50ms, and impulse from 0-50ms were similar for 
twitch and octet stimulation (p≥0.41). Twitch TPT and HRT displayed excellent ICC 
values (0.89 and 0.86, respectively) and very low CV values (3.6 and 4.9%, respectively). 
Mmax P-P and Mmax area fluctuated significantly across sessions (p=0.025 and p=0.033, 
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respectively) and demonstrated poor CV values (14.1 and 13.7%, respectively). However, 
the ICCs (0.95 and 0.93) were high for both measures.   
 This study demonstrated that measures of voluntary explosive force production 
are inconsistent during the first 50ms of force production, but become more consistent 
from 100ms onward. Furthermore, good reliability (CV<10.0%, ICC>.70) was shown for 
maximal voluntary force and force responses to octet and twitch stimulation. 
2.4 Ageing 
2.4.1. Young, Stokes, and Crowe (66) 
 The purpose of this study was to compare the cross sectional area (CSA) in the 
quadriceps  femoris muscles as well as isometric quadriceps strength of men in their 
twenties compared to men in their seventies. Twelve older men (mean age=75 yrs, 
weight=73kg) and twelve younger men (age=25 yrs, weight=74kg) volunteered to 
participate in this study. All of the elderly subjects were moderately active. Six of the 
young subjects participated in recreational sport and the other six participated in 
moderate physical activity. Isometric leg extensor strength was measured with the 
subjects seated in an adjustable, straight-backed chair with the leg flexed to 90 degrees. 
The isometric maximal voluntary strength was defined as the peak force maintained for at 
least 1 s of contraction. The highest recorded force of at least three maximal efforts was 
taken as the MVC. Quadriceps CSA was measured via bilateral transverse ultrasound 
scans at the mid-thigh. Subjects lay supine with their thigh supported at a 5-10 degree 
angle, the knee straightened, and the quadriceps relaxed. Four transverse scans were 
completed with the CSA taken to be the mean of the four values.   
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 The results of this study demonstrate that elderly men have markedly lower 
quadriceps strength (39%) and a decreased MVC/CSA ratio compared to young men. The 
author’s hypothesized that this was due to a difference in voluntary activation and/or the 
fiber type make-up of the muscles. There is also an association between MVC and CSA 
in older men that does not appear in younger men. The authors concluded that it is 
important to emphasize the use of age-matched normal data when measuring strength. 
2.4.2. Hakkinen, K., Pastinen, U-M., Karsikas, R., and Linnamo, V. (25) 
The purpose of this study was to examine the effects of age on voluntary 
isometric force in unilateral and bilateral conditions and to examine the effects of age on 
evoked force production compared to the force produced by combined voluntary and 
evoked muscle actions. Eleven young men (mean age ± SD; 29.0 ± 3.1 yrs), 12 middle-
aged men (49.6 ± 4.1 yrs), and 10 elderly men (67.2 ± 3.9 yrs) volunteered for this study. 
All subjects were considered healthy and habitually active, however, none had a 
background in strength training or competitive sport.  
Subjects were seated on a dynamometer and performed three to four maximal 
bilateral isometric contractions followed by two to three maximal unilateral isometric 
contractions of each leg. Subjects were instructed to contract and relax as fast as possible 
during each of these contractions. Peak force, force-time, and relaxation-time 
characteristics were recorded from each of these contractions. Electromyographic (EMG) 
information was recorded from the vastus lateralis (VL), vastus medialis (VM), and 
rectus femoris (RF). Electrostimulation was applied to the thigh at the motor point of the 
RF muscle using a 2 s, square pulse with a pulse rate of 50Hz. The first evoked condition 
included applying three separate maximal stimuli for both the right and left leg while the 
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subjects remained at rest. In the second evoked condition, subjects performed MVC’s 
while the supramaximal stimuli were applied.  
The results of this study showed no IEMG or force evidence of a bilateral deficit 
for the leg extensors in any of the age groups (p>0.05). However, according to the 
absolute force-time curve, the ability for explosive force production diminishes with age 
(p<0.05). Furthermore, there were differences in the relative force-time curves such that 
the bilateral force produced in the same short period of time relative to the maximal force 
was higher in young men (p<0.01). The relative neuromuscular activation was lower in 
the elderly than in the young adults during this same short period of time. These results 
indicate that the ability to rapidly recruit motor units decreases with age and affects the 
ability of elderly individuals to display explosive strength properties. Finally, evoked 
force was significantly lower in the elderly than in the young adults, while there was no 
difference between the middle-aged and elderly subjects, which may indicate that there is 
a peripheral component to the loss of strength observed with age.   
2.4.3. Hurley, Rees, and Newham (29) 
 
The purpose of this study was to compare strength, activation, proprioceptive 
acuity, postural stability, and functional activity of the quadriceps femoris muscles in 
young, middle-aged, and old adults. Twenty young (mean age = 23 yrs), 10 middle aged 
(mean age = 56 yrs), and 15 elderly (mean age = 72 years) subjects volunteered for this 
study. Quadriceps strength was measured by a strain gauge with the subjects seated and 
their hips and knees at 90 degrees of flexion. Subjects performed three maximal 
voluntary isometric contractions (MVC) of the quadriceps. Voluntary activation was 
estimated via twitch interpolation. To measure joint position sense (JPS), each subject 
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was seated with an electro-goniometer fixed to his or her leg. Subjects were asked to 
estimate their knee joint angle at 10 randomly assigned joint positions. The angle 
displayed on the goniometer was then compared to the estimated angle that the subject 
provided. Postural sway was measured while subjects stood on a force plate with three 
different stances: (1) bipedal with eyes closed, (2) bipedal with eyes open, and (3) 
monopedal with eyes open. Functional performance was measured via a timed up and go 
test, a timed walk, a timed stair ascent, a timed stair descent, and a calculated total time 
for all of the tests performed.  
The results of this study demonstrated that quadriceps strength was significantly 
lower in the older compared to the younger adults (p<0.001). Further, quadriceps strength 
was negatively correlated with age (r=-0.511, p<0.001). There was no difference in 
quadriceps activation between the young, middle-aged, and old subject groups (p>0.05), 
or relationship between age and quadriceps activation (p= 0.345). JPS was lower in the 
elderly than in the young (p<0.001) subjects and increasing age was associated with a 
decreased JPS (r= 0.603, p<0.001). In sway tests where subjects closed their eyes, the 
elderly and middle-aged groups were less stable (p<0.002). Elderly and middle-aged 
subjects were unable to maintain the monopedal stance for 15 s and at 7 s the elderly 
were significantly (p<0.005) less stable then the young and middle aged. The elderly 
subjects were significantly slower than the young and the middle-aged subjects in all of 
the individual functional performance tests (p<0.001) and the aggregate time (p<0.001). 
Furthermore, the aggregate functional performance time increased as subjects’ age 
increased (r=0.636, p<0.001), JPS decreased (r=-0.535, p<0.001), and as quadriceps 
strength decreased (r=-0.37, p<0.02).  
	   	  
	  
17	  
This study suggests that voluntary activation, and therefore central drive, is not 
the cause of thigh muscular weakness associated with age. The authors hypothesized that 
the decrease in JPS was due to decreased muscle spindle sensitivity. The combination of 
decreased strength and proprioceptive abilities appears to have led to an increase in 
postural sway in the elderly subjects.  
2.4.4. Bento, Pereira, Ugrinowitsch, Rodacki (10) 
 The purpose of this study was to determine the relationship between rate of torque 
development and peak torque in the lower limbs of elderly individuals with and without a 
history of falling. A secondary aim was to determine if these measures were related to the 
number of falls. Thirty-one women aged 60 years and older were split into three groups 
based on the number of falls they had experienced in the last 12 months. Group one 
(mean age ± SD age = 67.6 ± 7.5 yrs) had no history of falls, group two (66.0 ± 4.9 yrs) 
had experienced one fall, and group three (67.8 ± 8.8 yrs) experienced two or more falls. 
Subjects performed maximal isometric thigh abduction and adduction, leg flexion and 
extension, and dorsiflexion and plantar-flexion. Peak torque and rate of torque 
development were determined from the torque-time curves of each muscle action. Peak 
torque was measured as the highest torque obtained after the onset of contraction. Rate of 
torque development was measured as the slope of the curve from 20% to 80% of peak 
torque. The results of this study demonstrate that the rate of torque development in the 
leg flexor muscles of non-fallers was significantly greater than the rate of torque 
development observed in fallers. There was also a significant (p<0.05) relationship 
between peak torque in the leg flexors and the number of falls. However, there was no 
significant difference in peak torque of the leg flexors in non-fallers and fallers. Finally, 
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rate of torque development of the leg extensors was higher in non-fallers than in fallers, 
although not statistically significant. The authors concluded that rate of torque 
development was a fall-related determinant among the elderly while peak torque was not. 
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CHAPTER III 
METHODS 
Subjects 
 Fifteen older men between the ages of 65-88 years (mean ± standard deviation 
(SD) age = 72.3 ± 7.3 years; height = 178.2 ± 6.2 cm; mass = 81.0 ± 13.3 kg) volunteered 
for this study. Prior to testing, all subjects signed an informed consent, completed a 
health history questionnaire, and received physician’s clearance to participate in this 
study. All participants had a body mass index below 30 kg·m-2 and did not have any 
current or ongoing musculoskeletal injuries or neuromuscular diseases that involved the 
hip, knee, or ankle joints. Of the 15 participants, 14 reported engaging in 1-11 h•wk-1 of 
aerobic exercise and 9 reported 1–4 h•wk-1 of resistance exercise. This study was 
approved by the University of Nebraska-Lincoln Institutional Review Board for Human 
Subjects.  
Research Design 
 This was a repeated measures reliability study that required each subject to visit 
the laboratory on three separate occasions. Each laboratory visit was separated by 48-72 
hours and occurred at the same time of day (±2 hours). During the first study visit, 
subjects signed an informed consent and completed a health history questionnaire before 
being familiarized with the testing procedures. During visits two and three, subjects 
completed the following tests in order: (a) three electrically evoked isometric muscle 
actions of the leg extensors and (b) three 6-s maximal voluntary isometric contractions 
(MVIC) of the leg extensors.  
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Isometric Torque 
 Subjects were seated on a calibrated isokinetic dynamometer (Biodex System 3, 
Biodex Medical Systems, Inc., Shirley, NY, USA) with restraining straps securing their 
trunk, pelvis, and contralateral thigh. The axis of rotation of the dynamometer head was 
aligned with the lateral epicondyle of the right femur, and the right leg was tested for all 
subjects. The seat was tilted back so that there was a 120° between the thigh and the 
trunk to expose the femoral triangle for location of the femoral nerve trunk and delivery 
of the electrical stimuli. The leg was flexed to 90° between the leg and the horizontal 
plane for all muscle actions. In order to remove any slack resulting in a delay of the 
transmission of torque from the leg to the dynamometer’s potentiometer, the investigator 
placed a minimal baseline pressure on the lever arm prior to the initiation of the isometric 
muscle actions.  
 Isometric force (N) was recorded with a calibrated load cell (Omegadyne, model 
LC402, range 0-500 lbs; Stamford, CT, USA) that was fixed between the lever arm and 
the leg pad. Lever arm length (m) was measured and recorded prior to each experimental 
session. Force and lever arm length were then used to calculate torque using the equation: 
Torque (Nm) = Force (N) x Lever Arm Length (m).  
Electrically Evoked Isometric Muscle Actions 
 Transcutaneous electrical stimuli were delivered via bipolar surface electrodes 
placed over the femoral nerve in the lateral most corner of the femoral triangle. The 
electrical stimuli were delivered using a high-voltage (maximal voltage = 400 V), 
constant-current stimulator (Digitimer DS7AH, Herthfordshire, UK). Optimal stimulation 
electrode placements were determined by delivering single low-amperage exploratory 
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stimuli (20-40 mA) using a hand-held stimulation probe (Digitimer Bipolar Felt Pad 
Electrodes, Herthfordshire, UK). Electrode location was selected based on visual 
inspections of the twitch torque and the compound muscle action potential (M-Wave) 
amplitudes that were displayed on an external computer screen after each exploratory 
stimulus. Once the location was determined and marked, maximal stimulus intensity was 
determined by increasing the amperage in 20 mA increments until a plateau in peak-to-
peak M-wave (Mp-p) amplitude and twitch torque were observed after three consecutive 
increments. One hundred and twenty percent of the stimulus used to elicit Mp-p was used 
to evoke the femoral nerve trunk with a single 200 µs square wave impulse to ensure a 
supramaximal stimulus. Three supramaximal stimuli were then administered to record 
peak twitch torque from the leg extensors with 30 seconds of rest between each stimulus. 
Maximal Voluntary Isometric Muscle Actions 
 Subjects completed four, 4-s isometric warm-up leg extension muscle actions at 
25%, 50%, 75%, and 100% of their perceived effort with 30 s of rest between each 
muscle action. Following two minutes of rest after the warmup, subjects completed three, 
6-s MVICs of the leg extensors with two minutes of rest between each attempt. For each 
attempt, subjects were instructed to contract as “hard and fast” as possible when the 
investigator said “go!”. Loud, verbal encouragement was provided during each MVIC.  
Electromyography 
 Pre-gelled bipolar surface electrodes (Ag/AgCl, Quinton Quick Prep, Quinton 
Instruments Co., Bothell, WA, USA) were placed on the vastus lateralis muscle of the 
right thigh with an inter-electrode distance of 40 mm. The center of the bipolar electrode 
pair was placed at 66% of the distance between the anterior superior iliac spine (ASIS) 
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and the lateral superior border of the patella (27). The longitudinal axis of the bipolar 
electrode pair was parallel to the angle of pennation of the vastus lateralis fibers 
(approximately 20°) (15,22,38). A single pre-gelled surface electrode (Ag/AgCl, Quinton 
Quick Prep, Quinton Instruments Co., Bothell, WA, USA) was placed on the tibial 
tuberosity to serve as the reference electrode. In order to reduce inter-electrode 
impedance and increase the signal-to-noise ratio (8,54), local areas of the skin were 
shaved, abraded, and cleaned with isopropyl alcohol prior to the placement of the 
electrodes. Interelectrode impedance was measured using a digital multimeter (National 
Medical Sales, Mission Viejo, CA) to keep impedance below 2,000 Ω (8).  
Signal Processing 
The torque and EMG signals were sampled simultaneously at 2 kHz with a 
Biopac data acquisition system (MP150WSW, Biopac Systems, Inc., Santa Barbara, CA, 
USA). The signals were recorded and stored on a personal computer and processed off-
line with custom written software (Labview 11.0, National Instruments, Austin, TX, 
USA). The EMG signals were digitally filtered (zero-phase shift 4th-order Butterworth 
filter) with a band-pass of 10-999 Hz. The torque signal was low-pass filtered with a 15 
Hz cutoff (zero-phase shift 4th-order Butterworth filter). All subsequent analyses were 
completed on the filtered signals.  
The dependent variables included peak torque (PT), rate of torque development 
(RTD), and the electromechanical delay (EMD). Voluntary peak torque (PTV) was 
calculated as the highest consecutive 500 ms average torque value (Nm) obtained during 
the MVIC. The evoked peak twitch torque (PTE) was defined as the highest torque value 
(Nm) obtained after the onset of the evoked twitch.  
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Rate of torque development (RTD) was quantified using four different methods 
for voluntary and evoked muscle actions: (a) Voluntary (PRTDV) and evoked (PRTDE) 
peak rate of torque development were calculated as the peak of the first derivative of the 
torque signal (Nm·s-1) occurring between the onset of torque and peak torque, (b) RTD 
was measured from the first derivative of the torque signal as an average of 10 ms epochs 
over the first 250 ms (i.e. 0-10, 10-20, 20-30…240-250 ms) for voluntary muscle actions, 
and in 10 ms epochs up to PTE for evoked muscle actions, (c) RTD was measured as the 
slopes of the torque-time curve in time intervals of 0-30 (RTD30v), 0-50 (RTD50v), 0-
100 (RTD100v), and 0-200 (RTD200v) ms from the onset of torque for voluntary muscle 
actions (3) and as the slopes of the torque-time curve in time intervals of 0-30 (RTD30E), 
0-50 (RTD50 E), and 0-100 (RTD100 E) for evoked muscle actions. Unlike the voluntary 
muscle actions, the slope from 0-200 ms was not calculated for the evoked muscle 
actions because PTE occurred at approximately 100 ms, (d) Overall RTD was measured 
as the slope of the torque signal from the onset of torque to peak torque (Nm·s-1) for 
voluntary and evoked muscle actions.  
Voluntary electromechanical delay (EMDV) was defined as the time lag (ms) 
between the onset of the voluntary EMG amplitude and the onset of the torque response. 
Evoked electromechanical delay (EMDE) was defined as the time lag (ms) between the 
onset of the M-wave and the onset of the torque response. The onsets of torque and EMG 
amplitude were manually identified as the point where the torque or EMG signal crossed 
three standard deviation units above the respective signal baselines.  
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Statistical Analyses 
The average across the three voluntary or evoked attempts for each subject during 
both trials was used for statistical analyses. Means, standard deviations, and 95% 
confidence intervals using the studentized t-distribution were reported for each dependent 
variable (Table 1).  
 Test-retest reliability was quantified by calculating the intraclass correlation 
coefficient (ICC) for relative consistency among trials using Model “2,k” from Shrout 
and Fleiss (52):  
ICC2,k = 
𝑀𝑆𝑠  –   𝑀𝑆𝑒𝑀𝑆𝑠 + ! !"#!!"#!  
Where MSS was the mean square for subjects, MSe was the mean square error, 
MSt was the mean square total, k was the number of trials (k=2 for voluntary and 
evoked), and n represented the sample size. In addition, the 95% confidence interval for 
the ICC2,k was calculated according to the procedure described by Shrout and Fleiss (52) 
and McGraw and Wong (43), and the 95% confidence interval was used to test the null 
hypotheses that each ICC was equal to zero according to the recommendation of Vincent 
and Weir (59). 
 The standard error of the measurement (SEM) was reported as a measure of 
absolute consistency (62). The SEM was calculated using the following equation (28, 
53):  SEM =    𝑀𝑆𝑒 
 The coefficient of variation (CV) was calculated as a normalized measure of the 
SEM using the following equation (28): 
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CV = 𝑆𝐸𝑀𝐺𝑟𝑎𝑛𝑑  𝑀𝑒𝑎𝑛   ×  100 
A one-way repeated measures analyses of variance (ANOVA) was used to 
compare the means between trials one and two for systematic variability, and the p-values 
for this comparison are reported in Tables 1 and 2. In addition, the mean square values 
used to calculate the ICC2,k, SEM, and CV were derived from the ANOVA tables.  
The calculations for ICC, SEM, and CV were performed using a custom-written 
spreadsheet (Microsoft Excel for Mac 2011, Microsoft Corporation, Redmond, WA) 
based on the article by Weir (62). All other data analyses were performed using SPSS v. 
14.0 (SPSS Inc., Chicago, IL.). A type I error rate of ≤ 5% was considered statistically 
significant for all analyses.  
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CHAPTER IV 
ANALYSIS OF DATA 
RESULTS 
Table 1 shows the means, standard deviations, and 95% confidence intervals for 
voluntary and evoked PT, EMD, and RTD for trials one and two. Table 2 shows the 
means, standard deviations, and 95% confidence intervals for voluntary and evoked RTD 
during the 10 ms epochs for trials one and two. The reliability for PT, EMD, and RTD, 
and RTD during the 10 ms epochs are displayed in Tables 3 and 4, respectively. There 
were systematic decreases in PRTDV (p=0.01) and RTD200V (p=0.034), in RTD 
calculated in 10 ms epochs for voluntary muscle actions during 140-150 ms (p=0.03), 
150-160 ms (p=0.005), 160-170 ms (p=0.003), and 170-180 ms (p=0.004), and for 
evoked muscle actions during 80-90 ms (p=0.035) from trial one to two (Tables 3 and 4). 
 Figures 1 and 2 display the ICCs ± 95% confidence intervals for each dependent 
variable. The ICCs for RTD50E, EMDE, and voluntary RTD in 10 ms epochs from 30-60 
ms and from 120-180 ms exhibited 95% confidence intervals that included zero, which 
indicated that those ICCs were not different from zero (p>0.05). All other ICCs were 
greater than zero (p≤0.05).  
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DISCUSSION 
 In the present investigation, the ICCs for PT, EMD, and RTD during voluntary 
and evoked muscle actions ranged from 0.596 to 0.887 and from 0.625 to 0.984, 
respectively. For PTV and PTE, the ICCs were 0.887 and 0.974, respectively. In contrast, 
the ICCs for EMDV and EMDE were 0.596 and 0.625, respectively. The ICC for PRTDV 
was 0.799 and the ICC for PRTDE was 0.984. The ICCs for RTD30V, RTD50V, RTD100V, 
RTD200V, and overall RTDV ranged from 0.598-0.793, while for RTD30E, RTD50E, 
RTD100E, and overall RTDE, ICCs ranged from 0.943-0.980. Voluntary RTDs calculated 
in 10 ms epochs had ICCs ranging from 0.179-0.939, while evoked RTD in 10 ms epochs 
demonstrated ICCs ranging from 0.693-0.975 (Figure 2). Except for PRTD and RTD in 
10 ms epochs after 50 ms, CVs were higher for voluntary (11-41%) than evoked (7-24%) 
measures. Systematic decreases occurred from trial one to trial two for several voluntary 
measures of RTD (PRTDV, RTD200V, and for voluntary RTD in 10 ms epochs from 140-
180 ms), while there was only one systematic decrease for the evoked measures of RTD 
(the evoked RTD 10 ms epoch from 80-90 ms). Therefore, in the present study, 
qualitative comparisons of ICCs, SEMs, and CVs between voluntary and evoked 
measures of PT, EMD, and RTD indicated that, for these elderly men, voluntary and 
evoked PT were comparably reliable, EMD was comparably unreliable, and RTD was 
more reliable during evoked than voluntary muscle actions. These findings supported 
those of Jenkins et al. (35) for the reliability comparisons of voluntary and evoked PT and 
EMD, but did not support the comparable reliability between voluntary and evoked RTD 
in young men.  
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Winegard et al. (64) reported reliability coefficients (0.94-0.98) for voluntary and 
evoked PT during dorsiflexion and plantar-flexion in older men and women (ages 73-97 
yrs) that were similar to the ICCs for PTV and PTE in the current investigation (0.89 and 
0.97). Cannon et al. (17) reported greater reliability coefficients for voluntary (0.92-0.94) 
than evoked (0.84) PT, and ICCs of 0.80-0.81 for evoked overall RTD during isometric 
leg extension in both young and old women, which implied that reliability was similar for 
voluntary and evoked muscle actions regardless of age. Buckthorpe et al. (14) 
demonstrated that the reliability of PT and PRTD were greater during voluntary (0.95 and 
0.90) than evoked (0.83 and 0.80) muscle actions and that the ICCs for voluntary RTD 
calculated in time intervals of 0-50 ms and 0-100 ms were 0.80 and 0.90. In contrast, the 
present study showed better reliability for evoked (0.974 and 0.984 with no systematic 
error) than voluntary (0.887 and 0.799 with systematic error) PT and PRTD, and lower 
reliability for RTD50V and RTD100V (0.598 and 0.742) compared to Buckthorpe et al. 
(14). The reliability reported by Jenkins et al. (35) in young men, in combination with 
reliability for older men in the present study, suggested that voluntary and evoked PT and 
EMD were similar for young and older men. However, Jenkins et al. (35) reported that 
voluntary and evoked PRTD was similarly reliable in young men, which was not 
consistent with better reliability of evoked RTD than voluntary RTD in the present 
investigation. When examined collectively, these data suggested that voluntary RTD may 
be more reliable in young than old men, which may reflect an age-related decrease in the 
ability to consistently, voluntarily produce force rapidly. 
Christ et al. (19) previously raised concern with the accuracy of estimates of 
muscle function during maximal voluntary efforts requiring elderly individuals to 
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contract as hard and fast as possible. Voluntary ICCs and CVs for RTD30, RTD50, 
RTD100, RTD200, and overall RTD (0.598-0.793 and 9.8-37.9%) demonstrated lower 
relative and absolute reliability than evoked (0.943-0.980 and 6.8-11.5%). Apart from 0-
10 ms and 80-110 ms, voluntary RTDs in 10 ms epochs were unreliable; indeed, 11 of the 
25 ICCs were no different from zero (Figure 2). Previous studies have highlighted the 
importance of instructing subjects to contract as fast as possible in order to obtain the 
greatest rate of force development (9,50,51). However, it has also been recommended 
that subjects gradually build up force during an isometric muscle action in order to 
minimize the pain and/or discomfort (23). While subjects were instructed to contract as 
“…fast as possible,” it is possible that the differences in reliability between voluntary and 
evoked RTD variables observed in the present investigation were a result of fear of 
injury, apprehension, or discomfort related to explosive isometric muscle actions. 
Therefore, voluntary RTD variables recorded from older men should be interpreted with 
caution. However, RTD calculated in the earliest time phase (0-10 ms), during 80-110 ms 
after the onset of torque, or overall RTD were the voluntary RTD variables in the present 
study that yielded the highest ICCs and lowest CVs and may be appropriate for future 
studies. It is possible that additional familiarization sessions (i.e., greater than the one 
familiarization session used in the present study) for older adults are necessary to provide 
better reliability for voluntary RTD measures.   
The relative reliability of EMDV and EMDE were low in the present study (ICCs 
of 0.596 and 0.625, respectively). Jenkins et al. (35) suggested that the low ICCs 
associated with EMD may be a result of low between-subjects variability. Weir (62) 
explained that “the relative nature of the ICC is reflected in the fact that the magnitude of 
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an ICC depends on the between-subjects variability” (pg. 232). Specifically, the ICC will 
be low if the sample is homogenous, even if trial-to-trial variability is small (62). In the 
present study, the mean square between subjects (MSS) expressed as a percentage of the 
grand mean was 452% for EMDV and 166% for EMDE. In comparison, MSS was 1078% 
and 919% for PTV and PTE. These data indicated that between subjects variability was 
lower for EMD than PT. In addition, the CVs for EMDV and EMDE were lower than 
those previously reported in college-aged men (35). The 95% confidence interval for the 
EMDE ICC indicated that EMDE had no relative reliability. Therefore, despite the lower 
between-subjects variability that may have influenced the lower ICCs for EMD, EMDE 
should still be considered unreliable. 
Interpreting relative and absolute test-retest reliability has traditionally been 
qualitative and subjective. For example, Weir (62) stated that, “…the ICC for a test is 
context specific…” (p. 232). Streiner and Norman (54) noted that, “There is literally no 
such thing as the reliability of a test, unqualified; the coefficient has meaning only when 
applied to specific populations” (p. 112).  In addition, Cannon et al. (17) stated, “Because 
there is no preferred method to evaluate measurement reliability and no single statistical 
approach is universally recommended, assessing measurement reproducibility is 
somewhat problematic” (p. 632). In the present study, 95% confidence intervals were 
calculated about the ICCs, which provided a mechanism to test the null hypothesis that 
each ICC was equal to zero. This technique was described by Vincent and Weir (59) as 
an alternative to the traditional null hypothesis statistical test. Therefore, a unique aspect 
of the present study was applying this method of hypothesis testing to evaluate the ICC. 
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Future studies should consider this evaluation of reliability to avoid the challenge of 
interpreting reliability. 
Conclusions 
 This was the first study, to our knowledge, to quantify the test-retest reliability of 
voluntary and evoked measurements of RTD in 10 ms epochs, and time intervals of 0-30, 
0-50, 0-100, and 0-200 ms. Furthermore, we are aware of no previous studies that have 
statistically evaluated ICCs with 95% confidence intervals. The results of the present 
study, in conjunction with a previous study (35), indicated that voluntary and evoked 
measurements of PT are comparably reliable in both young and old men. Voluntary and 
evoked EMD, however, exhibited lower ICCs than PT, which may be due to low 
between-subjects variability, but when evaluated with 95% confidence intervals, EMD 
was unreliable in the present study. Finally, except for RTD in 10 ms epochs after the 
initial 50 ms, evoked RTD demonstrated high reliability in older men. Voluntary RTD 
was only reliable when calculated in 10 ms epochs during the first 10 ms, 80-110 ms, and 
calculated as the overall RTD – all other voluntary RTD measures were unreliable in the 
present study. It is possible that additional familiarization sessions are needed to improve 
the reliability of voluntary RTD and/or EMD measures in older men. Alternatively, it is 
possible that older men may alter the rate at which they voluntarily produce torque as a 
protective mechanism or fear of injury (19), which may have caused the low reliability 
for voluntary RTD.  
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CHAPTER V 
SUMMARY 
 
Statement of Purpose 
 The purpose of the present study was to examine test-retest reliability for PT, 
RTD, and EMD calculated during voluntary and evoked muscle actions in elderly men.  
Procedures for Collection of Data 
 Fifteen older men between the ages of 65-88 years (mean ± standard deviation 
(SD) age = 72.3 ± 7.3 years; height = 178.2 ± 6.2 cm; mass = 81.0 ± 13.3 kg) volunteered 
to complete 3 supramaximal, electrically evoked muscle actions and 3 6-s MVICs of the 
leg extensors during two trials separated by 48-72 hrs. PT, EMD, and RTD were 
calculated during each of the muscle actions, averaged across mode during each trial, and 
then used to calculate the reliability for the two experimental sessions. 
Analysis 
Means, standard deviations, and 95% confidence intervals using the studentized t-
distribution were calculated for each dependent variable. A one-way repeated measures 
analyses of variance (ANOVA) was used to compare the means between trials one and 
two for systematic variability. In addition, the mean square values used to calculate the 
ICC (2,k), SEM, and CV were derived from the ANOVA tables. Test-retest reliability 
was quantified by calculating the intraclass correlation coefficient (ICC), the standard 
error of the measurement (SEM), and the coefficient of variation (CV).  
 
 
Findings 
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Voluntary and evoked PT demonstrated good reliability (ICCs = 0.887-0.974; 
CVs = 8.7%), whereas EMD may be considered unreliable (ICCs = 0.596-0.625; CVs = 
5.4-17.6%). The ICCs for voluntary PRTD, RTD30, RTD50, RTD100, RTD200, and 
overall RTD ranged from 0.598-0.799, while for evoked PRTD, RTD30, RTD50, 
RTD100, and overall RTD, ICCs ranged from 0.943-0.984. Voluntary RTDs in 10 ms 
epochs had ICCs ranging from 0.179-0.939, while evoked RTD in 10 ms epochs 
demonstrated ICCs ranging from 0.693-0.975. Except for PRTD and RTD in 10 ms 
epochs after 50 ms, CVs were higher for voluntary (11-41%) than evoked (7-24%) 
measures. Systematic decreases occurred from trial one to trial two for several voluntary 
measures of RTD, while there was only one for the evoked measures of RTD.  
Conclusions 
This was the first study, to our knowledge, to quantify the test-retest reliability of 
voluntary and evoked measurements of RTD in 10 ms epochs, and time intervals of 0-30, 
0-50, 0-100, and 0-200 ms. Furthermore, we are aware of no previous studies that have 
statistically evaluated ICCs with 95% confidence intervals. The results of the present 
study, in conjunction with a previous study (35), indicated that voluntary and evoked 
measurements of PT may be comparably reliable in both young and old men. Voluntary 
and evoked EMD, however, exhibited lower ICCs than PT, which may be due to low 
between-subjects variability, but when evaluated with 95% confidence intervals, EMD 
was unreliable in the present study. Finally, except for RTD in 10 ms epochs after the 
initial 50 ms, evoked RTD demonstrated high reliability in older men. Voluntary RTD 
was only reliable when calculated in 10 ms epochs during the first 10 ms, 80-110 ms, and 
calculated as the overall RTD – all other voluntary RTD measures were unreliable in the 
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present study. It is possible that additional familiarization sessions are needed to improve 
the reliability of voluntary RTD and/or EMD measures in older men. Alternatively, it is 
possible that older men may alter the rate at which they voluntarily produce torque as a 
protective mechanism or fear of injury (19), which may have caused the low reliability 
for voluntary RTD.  
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TABLE 1. The means, standard deviations, and 95% confidence intervals for voluntary 
and evoked PT, RTD, and EMD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable (Units) Trial One Trial Two P-value
Mean (±SD)   95% CI Mean (±SD)   95% CI
PTV  (Nm) 124.9 (±26.9) ±14.9 117.3 (±26.4) ±14.6 0.067
EMDV VL (ms) 50.1 (±11.9) ±6.6 43.9 (±11.8) ±6.5 0.060
PRTDV  (Nm·s-1) 936.2 (±233.5) ±129.3 824.7 (±228.8) ±126.7 0.010*
Voluntary RTD30V  (Nm·s-1) 270.5 (±134.0) ±134.0 265.2 (±169.9) ±94.1 0.888
RTD50V  (Nm·s-1) 419.9 (±176.4) ±97.7 394.6 (±211.1) ±116.9 0.653
RTD100V  (Nm·s-1) 574.9 (±180.5) ±99.9 534.8 (±195.4) ±108.2 0.380
RTD200V  (Nm·s-1) 469.8 (±89.3) ±49.4 428.5 (±101.4) ±56.2 0.034*
Overall RTDV  (Nm·s-1) 419.3 (±70.0) ±38.8 390.3 (±81.6) ±45.2 0.070
PTE (Nm) 33.6 (±12.9) ±7.1 32.8 (±12.1) ±6.7 0.437
EMDE VL (ms) 24.3 (±6.2) ±3.43 25.8 (±4.3) ±2.4 0.302
PRTDE  (Nm·s-1) 668.4 (±202.8) ±112.3 654.5 (±203.9) ±112.9 0.299
Evoked RTD30E (Nm·s-1) 314.9 (±164.3) ±91.0 323.3 (±154.4) ±85.5 0.541
RTD50E  (Nm·s-1) 429.6 (±175.2) ±97.0 432.6 (±175.4) ±97.1 0.826
RTD100E  (Nm·s-1) 369.5 (±114.4) ±63.4 363.9 (±111.1) ±61.5 0.545
Overall RTDE  (Nm·s-1) 366.5 (±86.7) ±48.0 349.5 (±80.7) ±44.7 0.113
P-value = type I error rate for the one-way repeated measures ANOVA across trials one and two. 
(*) Signifies that trial one was significantly greater (p<0.05) than trial two.
	   	  
	  
36	  
TABLE 2. The means, standard deviations, and 95% confidence intervals for voluntary 
and evoked RTD in 10 ms epochs. 
 
 
 
 
 
 
 
 
 
 
 
 
Rate of Torque 
Development 
Trial One Trial Two P-value
Calculated in Nm·s-1 Mean (±SD)   95% CI Mean (±SD)   95% CI
RTD 0-10 137.4 (±86.8) ±48.1 137.2 (±105.3) ±58.3 0.995
RTD 10-20 258.5 (±133.9) ±74.2 255.4 (±174.0) ±96.4 0.931
RTD 20-30 415.6 (±187.5) ±103.8 402.9 (±242.6) ±134.4 0.838
RTD 30-40 578.6 (±236.8) ±131.1 539.6 (±292.5) ±162.0 0.646
RTD 40-50 709.4 (±268.2) ±148.5 637.8 (±296.1) ±164.0 0.427
RTD 50-60 784.8 (±275.5) ±152.6 691.8 (±267.8) ±148.3 0.230
RTD 60-70 801.9 (±265.4) ±147.0 716.2 (±241.1) ±133.5 0.137
RTD 70-80 769.8 (±243.9) ±135.1 707.6 (±223.7) ±123.9 0.129
RTD 80-90 697.8 (±212.2) ±117.5 666.7 (±202.4) ±112.1 0.295
RTD 90-100 596.2 (±178.3) ±98.8 593.0 (±180.9) ±100.2 0.894
RTD 100-110 484.6 (±157.2) ±87.0 499.4 (±147.5) ±81.7 0.595
Voluntary RTD 110-120 388.6 (±155.3) ±86.0 400.7 (±108.0) ±59.8 0.735
RTD 120-130 329.3 (±160.0) ±88.6 318.1 (±84.3) ±46.7 0.781
RTD 130-140 313.5 (±151.3) ±83.8 267.1 (±87.3) ±48.3 0.236
RTD 140-150 330.4 (±127.0) ±70.34 250.0 (±97.3) ±53.9 0.030*
RTD 150-160 355.8 (±101.9) ±56.4 251.8 (±77.7) ±43.0 0.005*
RTD 160-170 379.6 (±90.1) ±49.9 274.2 (±69.6) ±38.6 0.003*
RTD 170-180 381.4 (±82.8) ±45.9 301.2 (±66.4) ±36.8 0.004*
RTD 180-190 357.7 (±74.7) ±41.3 316.9 (±77.5) ±42.9 0.051
RTD 190-200 318.2 (±65.2) ±36.1 315.5 (±88.0) ±48.8 0.790
RTD 200-210 278.3 (±68.8) ±38.1 297.7 (±89.9) ±49.8 0.265
RTD 210-220 237.9 (±81.8) ±45.3 267.6 (±87.5) ±48.5 0.063
RTD 220-230 207.0 (±87.1) ±48.2 233.8 (±87.4) ±48.4 0.093
RTD 230-240 186.1 (±103.1) ±57.1 204.3 (±90.1) ±50.3 0.352
RTD 240-250 178.0 (±111.0) ±61.5 185.6 (±92.4) ±51.2 0.735
RTD 0-10 155.7 (±124.8) ±69.1 165.0 (±102.6) ±56.8 0.451
RTD 10-20 311.5 (±169.1) ±93.7 321.8 (±157.7) ±87.3 0.548
Evoked RTD 20-30 477.5 (±214.2) ±118.6 483.1 (±212.1) ±117.5 0.769
RTD 30-40 594.4 (±232.3) ±128.6 588.7 (±238.1) ±131.9 0.794
RTD 40-50 608.6 (±203.6) ±112.7 604.5 (±203.5) ±112.7 0.851
RTD 50-60 525.0 (±142.7) ±79.0 517.0 (±142.2) ±78.8 0.711
RTD 60-70 407.5 (±99.5) ±55.1 386.6 (±91.1) ±50.4 0.326
RTD 70-80 268.3 (±101.7) ±56.3 259.4 (±62.4) ±34.5 0.688
RTD 80-90 206.0 (±91.2) ±49.9 185.3 (±68.2) ±37.8 0.035*
RTD 90-100 140.7 (±96.1) ±53.2 127.4 (±85.0) ±47.1 0.536
P-value = type I error rate for the one-way repeated measures ANOVA across trials one and two. 
(*) Signifies that trial one was significantly greater (p<0.05) than trial two.
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TABLE 3.  Absolute and normalized reliability for PT, EMD, and RTD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Voluntary Evoked
ICC2,k SEM CV ICC2,k SEM CV
PT (Nm) 0.887 10.5 8.7% 0.974 2.87 8.7%
EMD (ms) 0.596 8.3 17.6% 0.625 3.93 5.4%
PRTD (Nm·s-1) 0.799 102.9 11.7% 0.984 35.45 15.8%
RTD30 (Nm·s-1) 0.746 101.4 37.9% 0.975 36.59 11.5%
RTD50 (Nm·s-1) 0.598 150.8 37.0% 0.980 37.3 8.7%
RTD100 (Nm·s-1) 0.742 121.3 21.9% 0.977 25.03 6.8%
RTD200 (Nm·s-1) 0.786 48.2 10.7%
Overall RTD (Nm·s-1) 0.793 39.7 9.8% 0.943 27.91 8.1%
ICC2,k = Intraclass correlation coefficient; model 2,k (Shrout and Fleiss, 1979)
SEM = Standard error of the measurement
CV = Coefficient of variation; calculated as a normalized measure of SEM
	   	  
	  
38	  
TABLE 4.  Absolute and normalized reliability for RTD calculated in 10 ms epochs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Voluntary Evoked
ICC2,k SEM CV ICC2,k SEM CV
RTD 0-10 (Nm·s-1) 0.878 47.6 34.6% 0.959 32.8 29.2%
RTD 10-20 (Nm·s-1) 0.776 98.1 38.2% 0.962 45.9 28.6%
RTD 20-30 (Nm·s-1) 0.614 166.6 40.7% 0.975 50.4 24.1%
RTD 30-40 (Nm·s-1) 0.454 227.1 40.6% 0.972 58.9 25.5%
RTD 40-50 (Nm·s-1) 0.449 239.8 35.6% 0.962 59.0 29.5%
RTD 50-60 (Nm·s-1) 0.594 203.1 27.5% 0.919 58.2 41.6%
RTD 60-70 (Nm·s-1) 0.761 148.7 19.6% 0.789 56.3 59.7%
RTD 70-80 (Nm·s-1) 0.866 105.5 14.3% 0.693 59.6 71.8%
RTD 80-90 (Nm·s-1) 0.922 78.1 11.5% 0.925 24.3 30.7%
RTD 90-100 (Nm·s-1) 0.939 64.9 10.9% 0.762 57.7 64.5%
RTD 100-110 (Nm·s-1) 0.875 74.6 15.2%
RTD 110-120 (Nm·s-1) 0.679 96.3 24.4%
RTD 120-130 (Nm·s-1) 0.480 107.9 33.3%
RTD 130-140 (Nm·s-1) 0.460 102.4 35.3%
RTD 140-150 (Nm·s-1) 0.399 91.0 31.4%
RTD 150-160 (Nm·s-1) 0.263 81.0 26.1%
RTD 160-170 (Nm·s-1) 0.179 74.2 22.4%
RTD 170-180 (Nm·s-1) 0.346 59.6 17.4%
RTD 180-190 (Nm·s-1) 0.644 50.0 14.8%
RTD 190-200 (Nm·s-1) 0.782 48.6 15.2%
RTD 200-210 (Nm·s-1) 0.796 45.9 57.9%
RTD 210-220 (Nm·s-1) 0.828 40.4 47.8%
RTD 220-230 (Nm·s-1) 0.847 40.6 46.8%
RTD 230-240 (Nm·s-1) 0.837 51.7 53.9%
RTD 240-250 (Nm·s-1) 0.814 59.6 59.4%
ICC2,k = Intraclass correlation coefficient; model 2,k (Shrout and Fleiss, 1979)
SEM = Standard error of the measurement
CV = Coefficient of variation; calculated as a normalized measure of SEM
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FIGURE 1. Intraclass correlation coefficients for voluntary and evoked PT, EMD, and 
RTD. The error bars represent the ±95% confidence intervals associated with the 
intraclass correlation coefficient for each dependent variable. 
 
 
*95% confidence interval indicates that the intraclass correlation coefficient is no greater 
than zero. 
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FIGURE 2. Intraclass correlation coefficients for voluntary (solid line) and evoked 
(dashed line) RTD calculated in 10 ms epochs. The error bars represent the ±95% 
confidence intervals associated with the intraclass correlation coefficient for each 
dependent variable. 
 
†Systematic variability (trial one > trial two; p<0.05) for evoked RTD 
*Systematic variability (trial one > trial two p<0.05) for voluntary RTD  
#95% confidence interval indicates that the intraclass correlation coefficient is no greater 
than zero. 
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APENDIX A 
Glossary 
PT  peak torque 
EMD  electromechanical delay 
RTD  rate of torque development 
ICC  interclass correlation coefficient 
SEM  standard error of the measurement 
CV  coefficient of variation 
Nm    newton meters 
Nm·s-1  newton meters per second 
ms   milliseconds 
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                   APPENDIX B 
Human Performance Laboratory 
Center for Youth Fitness and Sports Research 
 Department of Nutrition and Health Sciences 
 110 Ruth Leverton Hall 
 University of Nebraska-Lincoln 
          Lincoln, NE 68583-0806 
 
Director:  Joel T Cramer, Ph.D. 
Statement of Informed Consent 
Title of Research Study 
Test-retest reliability of voluntary and evoked muscle actions to study neuromuscular 
function in the elderly 
Invitation to Participate 
You are invited to participate in this research study.  The following is provided in order 
to help you make an informed decision whether or not to participate.  If you have any 
questions, please do not hesitate to ask. 
Basis for Subject Selection 
You were selected as a potential volunteer because you are between the ages of 19 and 29 
You were selected as a potential volunteer because you are aged 65 years or older and in 
good health. If you wish to participate you must fill out a health history questionnaire. 
You will also fill out a nutritional status survey and risk of falls assessment form. You 
will be prevented from participating in this research study if there are indications from 
the health history questionnaire that you may have health risks. Such indications include 
symptoms suggestive of chest pain, breathing difficulties, irregular heart beat, kidney or 
liver problems, high blood pressure or cholesterol, and/or abnormal electrocardiogram 
(EKG). Muscle or skeletal disorders including previous or current ankle, knee, and/or hip 
injuries may also preclude you from participation in this study. A pacemaker or metal 
implant in either hip may also preclude you from participation in this study. You are also 
being asked to provide consent for the investigators to send a Medical Clearance form to 
your attending physician for physician’s clearance. By signing this document you are also 
consenting to allow the investigators to request medical clearance from your physician. If 
you have no muscle/skeletal disorders or disease that will prevent you from engaging in 
physical activity and your doctor has provided consent, you will be asked to perform the 
physical tests described below.  Overall, there are numerous health-related issues that 
may preclude you from participation in this study and inclusion will be determined on a 
subject-by-subject basis. 
Purpose of the Study 
The purpose of this research study is to examine the reliability of measures of leg muscle 
strength, hand-grip strength, and balance. This study will also assess your nutritional 
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status and risk of falls through the use of two short surveys. These measurements have 
significant implications in the elderly and have been associated with risk of falls and 
overall functional status. They are also used as outcome measures in clinical settings. 
You are being asked to participate because we need a sufficient number of subjects to 
calculate the reliability statistics. 
 
Explanation of Procedures 
• You will be asked to visit the Exercise Physiology Laboratory located in Ruth 
Leverton Hall (Room 211) on the UN-L East campus on three separate days, 
separated by 48 – 72 hours. Visit 1 will consist of deciding if you want to 
participate in the current study, reading the informed consent, filling out and 
completing a health history questionnaire, and completing a nutritional status 
assessment and risk of falls assessment surveys. This is the only time you will 
have to complete these documents. The information you provide on the health 
history questionnaire may disqualify you as a participant. You will then complete 
the following procedures on visits 2 and 3.  
• After "final" eligibility is determined, visits 2 and 3 will be scheduled and will 
include the following assessments: 
 
o Thigh skinfold thickness and thigh circumference. 
 
o Hand-grip strength will be measured 3 times with a common handgrip 
dynamometer with 30 seconds rest between trials.  
 
o The "Functional Reach Test," where the you will stand next to a wall with 
your arm held out in front of you. You will then reach as far as possible 
without taking a step. This is a measure of balance. The farther you can 
reach, the better your balance (which is associated with a lower risk of 
falls).  
 
o Sensor's will be placed on the skin of the thigh. In order for the readings 
from these sensors to be accurate, the areas on the skin must be shaved, 
dead skin rubbed off, and the area cleansed with rubbing alcohol. If you 
feel it is uncomfortable for the investigator to shave your thigh, you may 
request to shave it on your own. These sensors will record muscle activity 
during the leg extension exercises described below. 
 
o A 5-min warm-up on a treadmill, walking at 3.0 miles per hour.  
 
o After the warm-up, you will be seated on a strength-measuring device 
called an "isokinetic dynamometer," which is commonly used in physical 
therapy clinics. Straps will be placed across your chest, hips, thigh, and 
ankle to avoid extraneous movements during the strength tests. A second 
warm-up will be completed by practicing the leg extension exercises at 
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25%, 50%, 75%, and 100% of your best effort. You will then be asked to 
perform leg extension exercises as hard and fast as possible 3 times to 
measure strength where the machine will not move and 6 times for 
strength where the machine will allow movement of the leg. One minute 
of rest will be allowed among these trials. This machine will not add 
weight to your leg, rather it only tests the strength of your effort.  
 
o Electrical stimulation will be used to make your thigh muscles contract. 
About 60-80 stimulated contractions - with about 10 seconds rest between 
each - will be performed during lab visits 2 and 3. The exact number of 
contractions is based on your individual response to the electrical stimuli. 
A small electrical current will be used at first, then the current will be 
increases in a stepwise fashion to determine the minimal current necessary 
for a maximal twitch contraction. The machine will measure your strength 
during these stimulated contractions the same way it is measured during 
the contractions from your own efforts. After the optimal electrical current 
is determined, 9 electrically-stimulated leg extensions will be performed 
with 10 seconds rest between each where the machine will not move, and 
18 electrically-stimulated leg extensions will be performed with 10 
seconds rests between each where the machine will be allowed to move. 
The electrical stimulations will be applied to the femoral nerve at the top 
of the thigh. The electrical stimulation will be delivered using a single 
stimulus, a doublet stimulus, and a triplet stimulus. The differences 
between these stimuli are the frequency at which they are delivered, but 
you will not be able to tell the difference, other than the stimulus 
"intensity." The sensation of the electric stimulation is often described as a 
hard "flick" to the skin or a stern tendon tap. Electrical stimulation is also 
something that is used in physical therapy and rehab clinics. Furthermore, 
the Digitimer DS7AH (Herthfordshire,UK) that we will be using is FDA 
approved for use on humans (this is not a study on the equipment, rather 
the reliability of the properties of skeletal muscle as measured by evoked 
muscle actions). 
Total Time Commitment 
The total time commitment for the 3 visits in this study will be approximately 3 to 5 
hours with each visit lasting approximately 1 to 1.5 hours. Visits 1 and 2 will be 
separated by 24-48 hours and visits 2 and 3 will be separated by a minimum of 48 hours 
and visits 2 and 3 must be completed within 72 hours from the start of visit 2. The visits 
will be scheduled as follows; visit 1: Screening, Informed Consent, Health History 
Questionnaire, and assessment surveys (1.0 hours), visit 2: exercise protocol (1.5 hours), 
visit 3: exercise protocol (1.5 hours). 
Potential Risks and Discomforts 
The following are the potential risks and discomforts you may experience during this 
study: 
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• Electrode Preparation and Use – The use of electrodes and the preparation of the 
skin for their application may lead to the remote possibility of complications such 
as a rash or infection. 
• You may experience a slight discomfort (like a stern finger flick) from the muscle 
stimulation. You may experience minor skin irritation and redness from the 
shaving, rubbing, and alcohol cleansing. Finally, you may experience very minor 
muscle soreness from the leg contractions. 
• There are no known risks associated with this project that are greater than those 
ordinarily encountered in rehabilitative settings.  
• Heavy exercise can cause high or low blood pressure, fainting, irregular heart 
rhythm, chest pain, and very rarely, heart attack, stroke or cardiac arrest. The need 
for hospital admission is reported in less than six of every 10,000 exercise tests. 
Cardiac arrest is reported in less than one of every 10,000 exercise tests. 
Protection Against Risks 
To minimize any potential risks and/or discomforts, you will be given instructions for 
special stretches, which may aid in the elimination of any muscle soreness as a result of 
the tests. In addition, you will be asked repeatedly during the tests how you feel in 
relation to your ability to continue the test. Throughout all the tests, you will be 
monitored by laboratory personnel trained in Cardiopulmonary Pulmonary Resuscitation 
(CPR) and use of an Automated External Defibrillator (AED). In addition, you will be 
asked repeatedly if you feel you can continue the tests. 
Potential Benefits to Subjects 
You will be helping to advance the understanding of testing procedures used to 
commonly measure strength in the exercise physiology field. You may also gain an 
understanding of these testing results and procedures for your own benefit. Finally, a 
report will be provided to you that includes your heart rate, blood pressure, body mass 
index (BMI), handgrip and leg extensor strength, risk of falls status, and nutritional 
status. You may give this report to your doctor to provide a more comprehensive 
snapshot of your health. However, this report is not to be used for diagnosis or treatment. 
Subject Compensation 
You will receive a $50 stipend for completing the study. You will be paid at the 
completion of visit 2 and 3 and completion of the first visit will not result in 
compensation. The final two visits are worth $25 each. You will be paid in cash. 
In Case of Emergency Contact Procedures 
If you are injured while you are in Ruth Leverton hall during your participation in the 
study, inform one of the investigators who will contact a local health care provider. You 
may (and should) always contact any of the investigators listed at the end of this consent 
form if you have any questions. 
Medical Care in Case of Injury 
In the unlikely event that you should suffer an injury as a direct consequence of the 
research procedures described above, the acute medical care required to treat the injury 
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will be provided by the local community health care providers or your personal health 
care provided.  The cost of such medical care will be the responsibility of the subject.  
Assurance of Confidentiality 
Any information obtained from this study that could identify you will be kept strictly 
confidential. The information may be published in scientific journals or presented at 
scientific meetings, but your identity will be kept strictly confidential. All data collected 
as a result of your participation will be kept in a locked cabinet in the office of the 
primary investigator (Room 211 Ruth Leverton Hall). Your data will receive an 
identifying number and only the investigators will be able to identify you from your data. 
Your data will be compiled and only group data will be used for dissemination without 
identifying your name. For the purposes of future reference, your data will be stored for a 
minimum of 15 years.  
Rights of Research Subjects 
You may ask any questions concerning this research and have those questions answered 
before agreeing to participate in or during the study. Or you may call the investigator, 
Nathaniel Jenkins, at any time, (267) 987-9208. You may also contact Dr. Joel Cramer at 
his office phone, (402) 472-7533. Please contact the investigator: 
• if you want to voice concerns or complaints about the research 
• in the event of a research related injury. 
Please contact the University of Nebraska-Lincoln Institutional Review Board at (402) 
472-6965 for the following reasons: 
• you wish to talk to someone other than the research staff to obtain answers to 
questions about your rights as a research participant 
• to voice concerns or complaints about the research 
• to provide input concerning the research process 
• in the event the study staff could not be reached. 
Voluntary Participation Withdrawal 
You are free to decide not to participate in this study, or to withdraw at any time without 
adversely affecting your relationship with the investigators or the University of Nebraska. 
Your decision will not result in any loss of benefits to which you are otherwise entitled. 
You are voluntarily making a decision whether or not to participate in this research study. 
Your signature certifies that the content and meaning of the information on this consent 
form have been fully explained to you and that you have decided to participate having 
read and understood the information presented. Your signature also certifies that you 
have had all your questions answered to your satisfaction. If you think of any questions 
	   	  
	  
53	  
during this study, please contact the investigators. You will be given a copy of this 
consent form to keep. 
_________________________________________ _____________________ 
Signature of Research Participant Date 
 
 
 
_____________________________ 
Printed name of Research Participant  
 
My signature as witness certifies that the subject signed this consent form in my presence 
as his/her voluntary act and deed. 
_________________________________________ _____________________ 
Signature of Investigator Date 
 
Investigators: 
Nathaniel Jenkins work phone (402) 472-2690 
 home phone (267) 987-9208 
Joel Cramer work phone (402) 472-7533 
 home phone (402) 405-4345 
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PRE-EXERCISE TESTING HEALTH STATUS QUESTIONNAIRE 
 
Subject Number __________________________    Date                         
______________ 
 
Work Phone _______________________  Home Phone_____             
__________ 
 
Birthday (mm/dd/yy)____/_____/_____   
 
Person to contact in case of emergency ______________Emergency Contact 
Phone_______ 
 
Personal Physician _______________________  Physician’s Phone___________ 
 
Gender ______    Age ______(yrs) Have you gained or lost weight over the past year? 
Yes / No  
     If yes, how much? ________________ 
 
Do you currently have a pacemaker? (YES/NO)  _________ 
Do you have metal in your hip (hip replacement)? (YES/NO) ________ 
 
A. JOINT-MUSCLE STATUS (PCheck areas where you currently have problems) 
 
 Joint Areas      Muscle Areas 
 (    )  Wrists      (    )  Arms 
 (    )  Elbows      (    )  Shoulders 
 (    )  Shoulders      (    )  Chest 
 (    )  Upper Spine & Neck    (    )  Upper Back & Neck 
 (    )  Lower Spine     (    )  Abdominal Regions 
 (    )  Hips      (    )  Lower Back 
 (    )  Knees      (    )  Buttocks 
 (    )  Ankles      (    )  Thighs 
 (    )  Feet      (    )  Lower Leg 
 (    )  Other__________________   (    )  Feet 
        (    )  Other_______________ 
 
B.   HEALTH STATUS (PCheck if you previously had or currently have any of the 
following conditions) 
 
(    )  High Blood Pressure   (    )  Acute Infection 
(    )  Heart Disease or Dysfunction  (    )  Diabetes or Blood Sugar Level 
Abnormality 
(    )  Peripheral Circulatory Disorder  (    )  Anemia 
(    )  Lung Disease or Dysfunction  (    )  Hernias 
(    )  Arthritis or Gout    (    )  Thyroid Dysfunction 
(    )  Edema     (    )  Pancreas Dysfunction 
(    )  Epilepsy     (    )  Liver Dysfunction 
(    )  Multiply Sclerosis    (    )  Kidney Dysfunction 
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(    )  High Blood Cholesterol or   (    )  Phenylketonuria (PKU)  
         Triglyceride Levels   (    )  Allergic Reactions to Medication 
(    )  Loss of Consciousness           please 
describe____________________ 
(    )  Others That You Feel We Should Know     (    )  Allergic Reactions to Any Other 
substance   About__________                                             please 
describe_______________ 
(    )  Pregnant 
C.   PHYSICAL EXAMINATION HISTORY 
 
 Approximate date of your last physical 
examination______________________________ 
  
 Physical problems noted at that 
time__________________________________________ 
 
 Has a physician ever made any recommendations relative to limiting your level of 
 physical exertion? _________YES __________NO 
 If YES, what limitations were 
recommended?___________________________________ 
 __________________________________________________________________
______ 
 
 Have you ever had an abnormal resting electrocardiogram (ECG)?  
_____YES_____NO 
 
D.   CURRENT MEDICATION USAGE (List the drug name and the condition being 
managed) 
 
 MEDICATION      CONDITION 
__________________________  
 ____________________________________ 
__________________________  
 ____________________________________ 
__________________________  
 ____________________________________ 
 
E.   PHYSICAL PERCEPTIONS (Indicate any unusual sensations or perceptions.  PCheck 
if you have recently experienced any of the following during or soon after physical 
activity (PA); or during sedentary periods (SED)) 
 
PA SED       PA SED 
(    ) (    )  Chest Pain      (    ) (    )  Nausea 
(    ) (    )  Heart Palpitations “fast irregular heart beats” (    ) (    )  Light 
Headedness 
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(    ) (    )  Unusually Rapid Breathing   (    ) (    )  Loss of 
Consciousness 
(    ) (    )  Overheating     (    ) (    )  Loss of Balance 
(    ) (    )  Muscle Cramping     (    ) (    )  Loss of 
Coordination 
(    ) (    )  Muscle Pain     (    ) (    )  Extreme 
Weakness 
(    ) (    )  Joint Pain      (    ) (    )  
Numbness 
(    ) (    )  Mental Confusion 
(    ) (    )  Other________________________  (    ) (    )  Pacemaker 
 
F. FAMILY HISTORY (PCheck if any of your blood relatives . . . parents, brothers, 
sisters, aunts, uncles, and/or grandparents . . . have or had any of the following) 
 
 (    )  Heart Disease 
 (    )  Heart Attacks or Strokes (prior to age 50) 
 (    )  Elevated Blood Cholesterol or Triglyceride Levels 
 (    )  High Blood Pressure 
 (    )  Diabetes 
 (    )  Sudden Death (other than accidental) 
 
G. CURRENT HABITS (PCheck any of the following if they are characteristic of you current 
habits) 
 
 (    )  Smoking. If so, how many per day?         
 (    )  Regularly does manual garden or yard work 
 (    )  Regularly goes for long walks Hours per week?_______________                    
 (    )  Frequently rides a bicycle                Hours per week?_______________                      
 (    )  Frequently runs/jogs for exercise     Hours per week?_______________                      
 (    )  Regularly participates in a weight training exercise program Hours per 
week?______________ 
 (    )  Engages in a sports program more than once per week.  If so, what does the program 
consist of? 
          
__________________________________________________________________________
__ 
E. FALL HISTORY (PCheck the statement which best describes the number of falls you 
have experienced in the past year) 
 
 (    ) No falls in the past 12 months 
 (    ) One fall in the past 12 months 
(    ) Two falls in the past 12 months 
(    ) Three or more falls in the past 12 months 
 
If you experienced a fall, were there any resulting injuries (Yes/No)?  ________ 
If Yes, was hospitalization required (Yes/No)? _______ 
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Department of Nutrition and Health Science - University of Nebraska-Lincoln 
 
Test-retest reliability of voluntary and evoked muscle actions to study neuromuscular 
function in the elderly. 
 
To the Attending Physician of: _____________________________________                               
 
This individual has indicated that he wishes to participate in a research study 
investigating the reliability of voluntary and evoked muscle actions to study 
neuromuscular function in elderly men.  This project has been approved by the 
Institutional Review Board at the University of Nebraska-Lincoln. 
 
Description of the Study 
 
The purpose of this research study is to examine the reliability of voluntary and 
electrically-stimulated leg muscle strength, hand-grip strength, and balance measures in 
older men. These measures are often used as outcome variables in studies of muscle 
function in the elderly (1,2) and in clinical trials (3). However, the reliability of these 
measures are not often reported, especially in the elderly. Furthermore, it is the goal of 
our lab to establish test-retest reliability of our common measurements for use in future 
studies and clinical trials. 
 
This study will consist of three visits to the laboratory, separated by 48-72 hours. During 
visit one, participants will complete a “Mini Nutritional Assessment” and a survey 
assessing their risk of falls, along with the procedures outlined below. During each 
subsequent visit, the procedures outlined below will be performed. Prior to the beginning 
of the assessments, electromyography (EMG) and mechanomyography (MMG) sensors 
will be placed on the skins surface of the vastus lateralis muscle and on the tibial 
tuberosity, which will be used to assess neuromuscular function.  Our lab has previously 
performed and published these procedures and no one to date has reported any 
deleterious side-effects.   
  
Body Composition Assessment: 
 
• A skin fold and circumference measurement of the thigh will be taken. 
 
Balance Assessment 
 
• Subjects will perform the "Functional Reach Test," where the subject will stand 
next to a wall with their arm held out in front of them. They will then reach as far 
as possible without taking a step. This is a measure of balance. 
 
Strength Assessments: 
 
• Hand-grip strength will be measured 3 times with a common handgrip 
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dynamometer with 30 seconds rest between trials.  
 
• Sensor's will be placed on the skin of the thigh. In order for the readings from 
these sensors to be accurate, the areas on the skin must be shaved, dead skin 
rubbed off, and the area cleansed with rubbing alcohol (see attached picture). 
These sensors will record muscle activity during the leg extension exercises 
described below. 
 
• A 5-min warm-up on a treadmill, walking at 3.0 miles per hour.  
 
• After the warm-up, subjects will be seated on a strength-measuring device called 
an "isokinetic dynamometer," which is commonly used in physical therapy 
clinics. Straps will be placed across their chest, hips, thigh, and ankle to avoid 
extraneous movements during the strength tests. A second warm-up will be 
completed by practicing the leg extension exercises at 25%, 50%, 75%, and 100% 
of their best effort. Subjects will then be asked to perform leg extension exercises 
as hard and fast as possible 3 times for "static" strength where the machine will 
not move, but strength will be recorded, and 6 times for "dynamic" strength where 
the machine will allow movement of the leg throughout the range of motion. One 
minute of rest will be allowed among these trials. This machine will not add 
weight to their leg, rather it only tests the strength of their effort.  
 
• Electrical stimulation will be used to make the subject's thigh muscles contract. 
About 60-80 stimulated contractions - with about 10 seconds rest between each - 
will be performed during lab visits 2 and 3. The exact number of contractions is 
based on each individual's response to the electrical stimuli. A small electrical 
current will be used at first, then the current will be increases in a stepwise 
fashion to determine the minimal current necessary for a maximal twitch 
contraction. The machine will measure their strength during these stimulated 
contractions the same way it is measured during the contractions from the 
subject's own efforts. After the optimal electrical current is determined, 9 "static" 
electrically-stimulated leg extensions will be performed with 10 seconds rest 
between each (machine will not move), and 18 "dynamic" electrically-stimulated 
leg extensions will be performed with 10 seconds rests between each (machine 
will be allowed to move). The electrical stimulations will be applied to the 
femoral nerve at the top of the thigh. The electrical stimulation will be delivered 
using a single stimulus, a doublet stimulus, and a triplet stimulus. The differences 
between these stimuli are the frequency at which they are delivered, but the 
subject will not be able to tell the difference, other than the stimulus "intensity." 
The sensation of the electric stimulation is often described as a hard "flick" to the 
skin or a stern tendon tap. Electrical stimulation is also something that is used in 
physical therapy and rehab clinics. Furthermore, the Digitimer DS7AH 
(Herthfordshire,UK) that we will be using is FDA approved for use on humans 
(this is not a study on the equipment, rather the reliability of the properties of 
skeletal muscle as measured by evoked muscle actions)..  
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Please advise the investigators regarding any physical limitations and/or 
contraindications that this patient might have from engaging in this exercise study.           
 
Participants will not be allowed to participate (exclusion criteria) in this study if they:  
 
1.) have any orthopedic problems (e.g., previous surgery, joint replacements, etc.) 
or previously diagnosed neuromuscular disease that will prevent them from 
participating in the strength or flexibility assessment session or; 
2.) have any absolute or relative contraindication for exercise testing as outlined 
by the American College of Sports Medicine (provided below): 
 
Absolute Contraindications to Exercise Testing (check all that applies) 
q A recent significant change in the resting ECG suggesting 
significant ischemia, recent MI or other acute cardiac event 
q Unstable angina 
q Uncontrolled cardiac dysrhythmias causing symptoms or 
hemodynamic compromise 
q Symptomatic severe aortic stenosis 
q Uncontrolled symptomatic heart failure 
q Acute pulmonary embolus or pulmonary infarction 
q Acute myocarditis or pericarditis 
q Suspected or known dissecting aneurysm 
q Acute systemic infection, accompanied by fever, body aches, or 
swollen lymph glands 
 
Relative Contraindications to Exercise Testing (check all that applies) 
q Left main coronary stenosis 
q Moderate stenotic valvular heart disease 
q Electrolyte abnormalities (e.g. hypokalemia, hypomagnesemia) 
q Severe arterial hypertension (i.e. SBP>200 and/or DBP >110) at 
rest 
q Tachydysrhythmia or bradydysrhythmia 
q Hypertrophic cardiomyopathy and other forms of outflow tract 
obstruction 
q Neuromuscular, musculoskeletal, or rheumatoid disorders that are 
exacerbated by exercise 
q High-degree atrioventricular block 
q Ventricular aneurysm 
q Uncontrolled metabolic disease (e.g., diabetes, thyrotoxicosis, or 
myxedema) 
q Chronic infectious disease (e.g., mononucleosis, hepatitis, or 
AIDS) 
q Mental or physical impairment leading to inability to exercise 
adequately 
	   	  
	  
60	  
 
Pertaining to the above mentioned patient, I advise the following: 
 
 To my knowledge, there is no reason why this patient should not be allowed to 
participate in this study. 
 I recommend that this patient be allowed to participate in the study with the 
following 
restrictions:________________________________________________________
________________ 
 __________________________________________________________________
______________________________________________  
 I recommend that this patient should not be allowed to participate in the study for 
the following 
reasons:___________________________________________________________
________________ 
  
 __________________________________________________________________
______________________________________________ 
 
Physician’s Signature_______________________ Physician’s Name (Printed) _________________________________ 
 Date_____________  
 
Physician’s Signature ______________________________________ 
 
If you have any questions about this form, please contact: Nathaniel D.M. Jenkins, 
Graduate Assistant, at Phone: 267-987-9208, Email: nathaniel.jenkins@unl.edu  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  
